Back to Search
DANIELLE THAMM, PHARMD
PHARMD
Pharmacist
NPI: 1841701224Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
PST.022123(LA)
Research & Publications (20)
Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature.
PMID 19330034·PLoS One·2009
3-trial
Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma.
PMID 19417014·Clin Cancer Res·2009
7-preclinical
Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers.
PMID 19422256·Langmuir·2009
8-other
Polymer-modified gadolinium metal-organic framework nanoparticles used as multifunctional nanomedicines for the targeted imaging and treatment of cancer.
PMID 19290624·Biomacromolecules·2009
7-preclinical
GS-9219--a novel acyclic nucleotide analogue with potent antineoplastic activity in dogs with spontaneous non-Hodgkin's lymphoma.
PMID 18451250·Clin Cancer Res·2008
7-preclinical
Glucose transporter 1 expression in canine osteosarcoma.
PMID 19178673·Vet Comp Oncol·2008
7-preclinical
Serum vascular endothelial growth factor concentrations and postsurgical outcome in dogs with osteosarcoma.
PMID 19178672·Vet Comp Oncol·2008
7-preclinical
Dose-escalating vinblastine for the treatment of canine mast cell tumour.
PMID 19178670·Vet Comp Oncol·2008
7-preclinical
NOD/SCID mouse model of canine T-cell lymphoma with humoral hypercalcaemia of malignancy: cytokine gene expression profiling and in vivo bioluminescent imaging.
PMID 19178662·Vet Comp Oncol·2008
7-preclinical
Systems biology approach to identification of biomarkers for metastatic progression in cancer.
PMID 18793472·BMC Bioinformatics·2008
8-other
Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone.
PMID 18700956·BMC Vet Res·2008
7-preclinical
Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma.
PMID 17502972·Cancer Immunol Immunother·2007
7-preclinical
Biological and molecular characterization of a canine hemangiosarcoma-derived cell line.
PMID 16256156·Res Vet Sci·2006
7-preclinical
Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high-risk canine mast cell tumour: 61 cases.
PMID 16820715·J Vet Med Sci·2006
7-preclinical
Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
PMID 16426175·J Am Vet Med Assoc·2006
7-preclinical
Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation.
PMID 16000580·Clin Cancer Res·2005
7-preclinical
Plasma synthesis of carbon magnetic nanoparticles and immobilization of doxorubicin for targeted drug delivery.
PMID 15461188·J Biomater Sci Polym Ed·2004
7-preclinical
Imatinib mesylate inhibits platelet-derived growth factor activity and increases chemosensitivity in feline vaccine-associated sarcoma.
PMID 15108021·Cancer Chemother Pharmacol·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 7623 HIGHWAY 165
COLUMBIA, LA 71418 - Phone
- (318) 649-6410
Quick Facts
- NPI
- 1841701224
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile